Pharmaceutical Analytical Impurities
The global supply chain for medicines includes manufacturers and suppliers of drug products and their ingredients from around the world. To safeguard patient and practitioner trust in medicines, manufacturers must ensure that impurities in their drug products and their ingredients are properly controlled regardless of who makes them and how they are produced.
Thus, impurity analysis and profiling is critical during drug development and throughout the product life cycle. Our new suite of Pharmaceutical Analytical Impurities*, together with our portfolio of official USP Reference Standards, provides for a comprehensive solution to your research and analytical needs.
Pharmaceutical Analytical Impurities are released through a USP quality process designed to ensure identity and quality appropriate for analytical applications. These impurities are supported with a product information sheet for each batch. By using impurities from your most trusted source, USP’s Pharmaceutical Analytical Impurities, like official USP Reference Standards, can help you to save time and resources and reduce risks associated with quality and consistency.